Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GPRC5D is an orphan G protein-coupled receptor (GPCR) belonging to the class C family. It is predominantly expressed in hard keratinized tissues like hair and nails, and highly expressed in multiple myeloma cells, but shows low expression in most other normal human tissues. While its exact biological function remains unclear, it is implicated in hair and nail development. GPRC5D is a therapeutic target for multiple myeloma, with immunotherapies like CAR T-cell therapy and bispecific antibodies (e.g., talquetamab) showing promising efficacy due to its restricted expression profile, which reduces off-target effects. Structural studies reveal GPRC5D forms dimers, influencing drug binding characteristics.
Bispecific antibody that binds to CD3 on T cells and GPRC5D on tumor cells, leading to T cell-mediated tumor cell killing.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G protein-coupled receptor class C group 5 member D (GPRC5D).